Categories
Top stories

Emerging Trends: Therapeutic Obstructive Sleep Apnea Device Market Sees Promising Growth in 2020

Global Therapeutic Obstructive Sleep Apnea Device market was valued at $ 4,661.6 Million in 2018 and is expected to reach of $ 9,561.3 Million by 2026, growing at a CAGR of 9.6% over the forecast period.

Obstructive sleep apnea is caused due to the blockage of the airways. This happens during sleep when the tongue folds with the soft palate and stops the air to pass on against the throat. It is being estimated that most of the mid age population tends to experience obstructive sleep apnea more than 5 times in half an hour.

Increasing number of cases in the sleep apnea is expected to drive the market for the therapeutic obstructive sleep apnea devices. It has been estimated that, around 80% of the patient who are suffering from obstructive sleep apnea are not being treated. The ratio between the total number of patients facing the obstructive sleep apnea and the patient who is being diagnosed is very minimal, so rising awareness among the patient can lead to the growth of the therapeutic obstructive sleep apnea market. Lack of awareness regarding the effects caused due to the obstructive sleep apnea such as, high blood pressure, diabetes, obesity and sometime the death of the patient may occur due to negligence and unawareness. Government initiative to raise the awareness among the people and the advanced technologies expected to give a boost to the overall obstructive sleep apnea therapeutic devices market.

The main reason for dissension of therapeutic obstructive sleep apnea devices is due to the lack of acceptance from the patients, this is mainly due to the discomfort and anxiety caused by the mask. The cost of therapeutic obstructive sleep apnea devices market is very high as compared to the other sleep apnea disease. The cost is the main constraint for the increase of the therapeutic obstructive sleep apnea devices market.

Depending on the type the positive airway pressure segment held the largest market size in 2018 for $2,187.8 million and is expected to reach $4,542.3 million by 2026, at a CAGR of 9.7%. Positive airways reduce the sleep apnea occurrence and protect the airways from closing. The oral application is estimated to grow at 9.5% CAGR by generating revenue by $1,768.2 million by 2026. It is expected to offer patient with greater satisfaction. Oral applications are portable, flexible and easy to use, so American Academy of Sleep Medicine (AASM) suggested to wear oral application with severe obstructive sleep apnea, who cannot wear and use positive airway pressure.

Due to the rising number of hospitals and growing investment in healthcare the hospitals and sleep laboratories segment is anticipated to drive the market over the forecast period. Hospitals and sleep laboratories segment accounted for $2,569.3 million in 2018 and is expected to rise at a CAGR of 9.4% in the forecast period.

North America holds the largest market share for the therapeutic obstructive sleep apnea devices market. This region registered 10.2% CAGR and is anticipated to generate a revenue of $3,970.7 million by 2026. The Asia-Pacific is the largest growing market for the therapeutic obstructive sleep apnea devices as most of the Asian countries are not developed in the medical facilities and are unaware of the therapeutic obstructive sleep apnea devices. It is projected that the region sleep apnea devices market is expected to grow at $1,777.7 million by 2026 at a CAGR of 9.0%.

The major key players in the therapeutic obstructive sleep apnea devices market are Invacare Corporation GE Healthcare, Compumedics Limited, BMC Medical Co., Fisher & Paykel Healthcare, Cadwell Laboratories Inc., Ltd, Braebon Medical Corporation, Becton Dickinson (CareFusion Corporation), Curative Medical Inc., ImThera Medical, Inc.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Categories
All News

Therapeutic Obstructive Sleep Apnea Device Market to Benefit from Rapid Technological Advancements During the Forecast Period

The global therapeutic obstructive sleep apnea device market is expected to generate a revenue of $9,561.3 million at a CAGR of 9.6% during the forecast period, according to a recent report published by Research Dive. The inclusive report provides a brief overview of the current scenario of the market including significant aspects of the market from growth factors, challenges, other market dynamics, restraints and various opportunities during the forecast period. The report also provides all the market figures making it easier and helpful for the new participants to understand the market.

Market Dynamics

The main growth attributor behind the growth of the therapeutic obstructive sleep apnea is the rising awareness about the sleep apnea device. Left untreated, obstructive sleep apnea may further result in different health issues such as high blood pressure, diabetes. There is rising awareness about the fatality of sleep apnea and the positive applications of sleep apnea devices which is expected to be one of the major driving factor of the therapeutic obstructive sleep apnea devices market.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/39

The high cost of sleep apnea devices and claustrophobic experience that the patients have to go through while using these devices, are the major restraints behind the growth of therapeutic obstructive sleep apnea devices market.

The report has bifurcated the market into different segments based on type, end-use, and regional outlook.

Positive airway pressure segment will be the most lucrative

Positive airway pressure segment accounted for $2,569.39 million in 2018 and is further projected to generate a revenue of $5,218.43 million in 2026. Positive airway pressure helps in getting rid of the nighttime apnea cases and prevents the airways from collapse. This is one of the main reason behind the growth of the industry.

Sleep laboratories and hospital segment will be the most profitable

Hospital and sleep laboratories segment is projected to grow with $ 5,218.43 million in 2026. Increasing number of clinics, rising health care expenditure, and safety for the patient is expected to boost the segment.

North America will dominate the market

North America regional market reached the market size of $1,850.6 million in 2018 and is further expected to reach $ 3,970.7 million by 2026, at a CAGR of 10.2%. Increasing incidents of sleep apnea and rising geriatric population in this region is predicted to be the main growth attributor of the market.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/39

Key Market Players and Strategies

The leading players of the global therapeutic obstructive sleep apnea devices market include –

  1. Becton Dickinson (CareFusion Corporation)
  2. BMC Medical Co., Ltd
  3. Braebon Medical Corporation
  4. GE Healthcare
  5. Cadwell Laboratories Inc.
  6. Curative Medical Inc.
  7. Compumedics Limited
  8. Invacare Corporation
  9. ImThera Medical, Inc.
  10. Fisher & Paykel Healthcare

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://industrialresearchworld.blogspot.com/

Categories
All News

Therapeutic Obstructive Sleep Apnea Device Market Size, Industry Analysis, Market trends, Cost and Forecasts to 2026

The global therapeutic obstructive sleep apnea device market is expected to generate a revenue of $9,561.3 million at a CAGR of 9.6% during the forecast period, according to a recent report published by Research Dive. The inclusive report provides a brief overview of the current scenario of the market including significant aspects of the market from growth factors, challenges, other market dynamics, restraints and various opportunities during the forecast period. The report also provides all the market figures making it easier and helpful for the new participants to understand the market.

Market Dynamics

The main growth attributor behind the growth of the therapeutic obstructive sleep apnea is the rising awareness about the sleep apnea device. Left untreated, obstructive sleep apnea may further result in different health issues such as high blood pressure, diabetes. There is rising awareness about the fatality of sleep apnea and the positive applications of sleep apnea devices which is expected to be one of the major driving factor of the therapeutic obstructive sleep apnea devices market.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/39

The high cost of sleep apnea devices and claustrophobic experience that the patients have to go through while using these devices, are the major restraints behind the growth of therapeutic obstructive sleep apnea devices market.

The report has bifurcated the market into different segments based on type, end-use, and regional outlook.

Positive airway pressure segment will be the most lucrative

Positive airway pressure segment accounted for $2,569.39 million in 2018 and is further projected to generate a revenue of $5,218.43 million in 2026. Positive airway pressure helps in getting rid of the nighttime apnea cases and prevents the airways from collapse. This is one of the main reason behind the growth of the industry.

Sleep laboratories and hospital segment will be the most profitable

Hospital and sleep laboratories segment is projected to grow with $ 5,218.43 million in 2026. Increasing number of clinics, rising health care expenditure, and safety for the patient is expected to boost the segment.

North America will dominate the market

North America regional market reached the market size of $1,850.6 million in 2018 and is further expected to reach $ 3,970.7 million by 2026, at a CAGR of 10.2%. Increasing incidents of sleep apnea and rising geriatric population in this region is predicted to be the main growth attributor of the market.

Key Market Players and Strategies

The leading players of the global therapeutic obstructive sleep apnea devices market include –

  1. Becton Dickinson (CareFusion Corporation)
  2. BMC Medical Co., Ltd
  3. Braebon Medical Corporation
  4. GE Healthcare
  5. Cadwell Laboratories Inc.
  6. Curative Medical Inc.
  7. Compumedics Limited
  8. Invacare Corporation
  9. ImThera Medical, Inc.
  10. Fisher & Paykel Healthcare

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/39

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://industrialresearchworld.blogspot.com/

Categories
Top stories

Global Therapeutic Obstructive Sleep Apnea Devices Market Expected to reach of $ 9,561.3 Million by 2026 – Research Dive

Global obstructive sleep apnea market was valued at $ 4,661.6 Million in 2018 and is expected to reach of $ 9,561.3 Million by 2026, growing at a CAGR of 9.6% over the forecast period.

Obstructive sleep apnea is caused due to the blockage of the airways. This happens during sleep when the tongue folds with the soft palate and stops the air to pass on against the throat. It is being estimated that most of the mid age population tends to experience obstructive sleep apnea more than 5 times in half an hour.

Increasing number of cases in the sleep apnea is expected to drive the market for the therapeutic obstructive sleep apnea devices. It has been estimated that, around 80% of the patient who are suffering from obstructive sleep apnea are not being treated. The ratio between the total number of patients facing the obstructive sleep apnea and the patient who is being diagnosed is very minimal, so rising awareness among the patient can lead to the growth of the therapeutic obstructive sleep apnea market. Lack of awareness regarding the effects caused due to the obstructive sleep apnea such as, high blood pressure, diabetes, obesity and sometime the death of the patient may occur due to negligence and unawareness. Government initiative to raise the awareness among the people and the advanced technologies expected to give a boost to the overall obstructive sleep apnea therapeutic devices market.

The main reason for dissension of therapeutic obstructive sleep apnea devices is due to the lack of acceptance from the patients, this is mainly due to the discomfort and anxiety caused by the mask. The cost of therapeutic obstructive sleep apnea devices market is very high as compared to the other sleep apnea disease. The cost is the main constraint for the increase of the therapeutic obstructive sleep apnea devices market.

Depending on the type the positive airway pressure segment held the largest market size in 2018 for $2,187.8 million and is expected to reach $4,542.3 million by 2026, at a CAGR of 9.7%. Positive airways reduce the sleep apnea occurrence and protect the airways from closing. The oral application is estimated to grow at 9.5% CAGR by generating revenue by $1,768.2 million by 2026. It is expected to offer patient with greater satisfaction. Oral applications are portable, flexible and easy to use, so American Academy of Sleep Medicine (AASM) suggested to wear oral application with severe obstructive sleep apnea, who cannot wear and use positive airway pressure.

Due to the rising number of hospitals and growing investment in healthcare the hospitals and sleep laboratories segment is anticipated to drive the market over the forecast period. Hospitals and sleep laboratories segment accounted for $2,569.3 million in 2018 and is expected to rise at a CAGR of 9.4% in the forecast period.

North America holds the largest market share for the therapeutic obstructive sleep apnea devices market. This region registered 10.2% CAGR and is anticipated to generate a revenue of $3,970.7 million by 2026. The Asia-Pacific is the largest growing market for the therapeutic obstructive sleep apnea devices as most of the Asian countries are not developed in the medical facilities and are unaware of the therapeutic obstructive sleep apnea devices. It is projected that the region sleep apnea devices market is expected to grow at $1,777.7 million by 2026 at a CAGR of 9.0%.

The major key players in the therapeutic obstructive sleep apnea devices market are Invacare Corporation GE Healthcare, Compumedics Limited, BMC Medical Co., Fisher & Paykel Healthcare, Cadwell Laboratories Inc., Ltd, Braebon Medical Corporation, Becton Dickinson (CareFusion Corporation), Curative Medical Inc., ImThera Medical, Inc.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: [email protected]
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com